Gene · 23569
Papers4,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic Management. | Pharmaceuticals (Basel) | 2026 | 41754759 | PubTator, text mining | PubMed |
| From Inflammation to Thrombosis: The Prothrombotic State and Cardiovascular Risk in Inflammatory Bowel Disease. | Medicina (Kaunas) | 2026 | 41752670 | PubTator, text mining | PubMed |
| The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications. | Molecules | 2026 | 41752527 | PubTator, text mining | PubMed |
| Functional Foods as Modulators of Epigenetic Mechanisms Affecting Metabolic Health in Adolescence. | Int J Mol Sci | 2026 | 41752200 | PubTator, text mining | PubMed |
| NETosis-Dependent Generation of Immunodeficient Low-Density Neutrophils Exacerbates Sepsis-Induced Acute Lung Injury. | Int J Mol Sci | 2026 | 41752177 | PubTator, text mining | PubMed |
| PhIP-Seq: unveiling the complexity of antibody repertoires in health and disease. | Front Immunol | 2026 | 41743708 | PubTator, text mining | PubMed |
| Neutrophil activation, NETs formation, and inflammation in diabetic kidney disease: therapeutic perspectives. | Eur J Med Res | 2026 | 41736093 | PubTator, text mining | PubMed |
| Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy. | Expert Opin Drug Deliv | 2026 | 41729255 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in gynecological disease: pathogenic mechanisms and therapeutic opportunities. | Front Med (Lausanne) | 2026 | 41728621 | PubTator, text mining | PubMed |
| Immunomodulatory effects of oral microbiota in the pathogenesis of rheumatoid arthritis. | Front Immunol | 2026 | 41727451 | PubTator, text mining | PubMed |
| Citrullinated Histones as Emerging Host Defence Biomarkers: Understanding NETosis at the Bedside with the Backdrop of COVID-19. | Indian J Crit Care Med | 2026 | 41726357 | PubTator, text mining | PubMed |
| High-throughput chemical proteomics workflow for profiling protein citrullination dynamics. | Nat Commun | 2026 | 41723106 | PubTator, text mining | PubMed |
| Deep Learning-Based Structural Brain Age Estimation in Bipolar Disorder and Schizophrenia: A Single-Site Pilot Study. | Hum Brain Mapp | 2026 | 41714875 | PubTator, text mining | PubMed |
Dental plaque metabolites induce polymorphonuclear leukocyte death accompanying peptidyl arginine deiminase 4 and citrullinated protein release: Potential contribution to rheumatoid arthritis pathogenesis. | J Oral Biosci | 2026 | 41714052 | PubTator, text mining | PubMed |
| Neutrophils in the hepatocellular carcinoma microenvironment: orchestrators of progression and immunity. | Front Immunol | 2026 | 41710884 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps and microglia/macrophages interactions in stroke: from thromboinflammation to immunotherapy. | Front Immunol | 2026 | 41710878 | PubTator, text mining | PubMed |
| Standardized Extract of Flavonoids from Smilax glabra Alleviates Gouty Arthritis by Multi-Target Inhibition of Neutrophil Extracellular Traps via the Raf/ERK and Histone Citrullination Pathways. | J Inflamm Res | 2026 | 41709965 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in rheumatoid arthritis: biomarkers, drivers, and emerging therapeutic targets. | Clin Exp Immunol | 2026 | 41703739 | PubTator, text mining | PubMed |
| Mitochondrial Metabolism in Neutrophils: Emerging Roles in Inflammatory Skin Diseases. | Br J Dermatol | 2026 | 41703724 | PubTator, text mining | PubMed |
| Evaluation of NETosis-related biomarkers in glioblastoma multiforme: PAD4 as a potent diagnostic predictor. | J Neurooncol | 2026 | 41703362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23569/papers?page=9